Whistleblowers: Merck hid declining efficacy of MMR shot

Two former Merck ($MRK) employees lodged a whistleblower suit against the drugmaker, alleging that it overstated the effectiveness of its MMR vaccine. The False Claims Act lawsuit says Merck didn't revise its claims about the combination shot's efficacy, despite the fact that it had become less effective. So, the employees say, government health programs paid for the product for 10 years without knowing it didn't live up to the company's claims. Story

 

Suggested Articles

Moderna’s shares shrunk by nearly 5% before the long holiday weekend Thursday after a report out by Stat said the biotech was delaying its trial.

Keep your post-pandemic trials on track: learn how the right clinical supply chain partner can help sponsors avoid trial disruption. Read now>>

Helsinn Group and MEI Pharma penned a near $500 million biobucks pact for experimental blood cancer drug pracinostat back in 2016.